key: cord-0974450-cs4dsxyx
authors: Sawires, R.; Pearce, C.; Fahey, M.; Clothier, H.; Gardner, K.; Buttery, J.
title: Snotwatch COVID-Toes: An ecological study of chilblains and COVID-19 diagnoses in Victoria, Australia
date: 2022-04-22
journal: nan
DOI: 10.1101/2022.04.21.22274140
sha: 02e6d7e4f6450cf01c880b0ed4cfa04a5f10c529
doc_id: 974450
cord_uid: cs4dsxyx

Background The COVID-19 pandemic has caused widespread illness with varying clinical manifestations. One less-commonly-reported presentation of COVID-19 infection is chilblain-like lesions. Aims We conducted an ecological analysis of chilblain presentations in comparison with confirmed and suspected COVID-19 infections in a primary care setting to establish that a relationship exists between the two. Study Design Our study collated data from three Primary Health Networks across Victoria, Australia, from 2017-2021, to understand patterns of chilblain presentations prior to and throughout the pandemic. Using a zero-inflated negative binomial regression analysis, we estimated the relationship between local minimum temperature, COVID-19 infections and the frequency of chilblain presentations. Results We found a 5.72 risk ratio of chilblain incidence in relation to COVID-19 infections and a 3.23 risk ratio associated with suspected COVID-19 infections. COVID-19 infections were also more strongly associated with chilblain presentations in 0-16-year-olds throughout the pandemic in Victoria. Conclusion Our study statistically demonstrates that chilblains are significantly associated with COVID-19 infections in a primary care setting. This has major implications for clinicians aiming to diagnose COVID-19 infections or determine the cause of a presentation of chilblains. Additionally, we demonstrate the utility of large-scale primary care data and its potential application to monitoring the spread of COVID-19 infections across the state, supporting current epidemiological efforts for COVID-19 tracking.

3 42 Additionally, we demonstrate the utility of large-scale primary care data and its potential 43 application to monitoring the spread of COVID-19 infections across the state, supporting 44 current epidemiological efforts for COVID-19 tracking.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (Figure 1 ). POLAR is an end-to-end analytics platform that collects and processes 71 electronic medical record information from general practices on behalf of PHNs. POLAR is 72 both a patient-level clinical decision support tool and a population health analytics platform. 88 Inclusion criteria were any diagnoses of chilblains, COVID-19 disorder, or suspected COVID-89 19 disorder recorded in any Victorian general practice located in one of the three . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 104 All data were then aggregated by the week of the year, where the weeks were calculated 105 from Monday to Sunday. The first and last weeks of the year were included independently 106 regardless of the day of the week they started or ended, respectively.

107 Statistical Analysis 108 The coding program, R (version 4.0.2), 12 was applied through RStudio (version 1.2.5) 13 for 109 statistical analysis of temporal data. Following fit testing of the distribution of our data, we 110 determined that conducting a zero-inflated negative binomial regression analysis would be 111 the most suitable technique for modelling our data. We created a multivariate model, which 112 used weekly minimum temperature, COVID-19 and suspected COVID-19 diagnoses to . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 207 Our findings showed that COVID-19 disorder diagnoses were most strongly associated with 208 chilblains presentations in the same week, whereas suspected COVID-19 disorder was 209 associated with chilblains presentations in the preceding and following weeks more 210 strongly.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The key advantage of our study compared to existing literature is that our ecological study 242 design yields a significant sample size. This adds significant power to our analysis and the 243 findings of our study. This study design also enabled us to meaningfully analyse whether 244 leads and lags existed between the timing of our diagnoses. Decreasing temperature is a key 245 cause of chilblains presentations and our study accounted for this by including these data in 246 our analysis. This means that the increase in chilblains presentations in 2020 and 2021 could 247 be more reliably associated with COVID-19. Additionally, the low p-value for significance in 248 our study gives greater confidence in the strength of our associations.

249 Nevertheless, there are some key limitations to our dataset. Over the course of the 250 pandemic, most COVID-19 diagnoses in Victoria were not made in a GP setting. As such, our 251 chilblains diagnosis data are only a subset of all COVID-19 infections that occurred in the last 252 two years. There is also uncertainty around how general practitioners coded COVID-19 253 diagnoses and whether there was a time delay between a patient having a confirmed 254 COVID-19 infection and their general practice visit at which this diagnosis would have been 255 recorded. We included suspected COVID-19 diagnosis in our analysis for completion, but this 256 is an unreliable measure of COVID-19 infection in the state and may not accurately . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 22, 2022. ; https://doi.org/10.1101/2022.04.21.22274140 doi: medRxiv preprint

Classification of the cutaneous manifestations of 281 COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Evidence-Based Review

Chilblain-like lesions on 286 feet and hands during the COVID-19 Pandemic

Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic

Chilblain-Like Lesions (CLL) Associated With 291 COVID-19

Clinical characteristics, etiologic associations, laboratory 296 findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 297 104 patients at Mayo Clinic

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 300 countries

Do we have serological evidences that 302 chilblain-like lesions are related to SARS-CoV-2? A review of the literature

R Development Core Team. R: A language and environment for statistical computing

Austria: R Foundation for Statistical Computing; 2010. 312 13. RStudio Team. RStudio: Integrated Development Environment for R

Chilblain-like lesions during the COVID-19 pandemic: early or 318 late sign?

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric . the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 322 infection

Cutaneous manifestations 324 of SARS-CoV-2 infection: a clinical update

Chilblain-327 like lesions during COVID-19 epidemic: a preliminary study on 63 patients

COVID-19 and cutaneous 330 manifestations: a systematic review

Pernio (Chilblains), SARS-CoV-2, and COVID Toes 332 Unified Through Cutaneous and Systemic Mechanisms

Major cluster of 335 paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of 336 lifestyle changes due to lockdown

When interferon tiptoes through COVID-19: Pernio-338 like lesions and their prognostic implications during SARS-CoV-2 infection

Timing of PCR 341 and antibody testing in patients with COVID-19-associated dermatologic manifestations

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 22, 2022. ; https://doi.org/10.1101/2022.04.21.22274140 doi: medRxiv preprint